DeVita, Vincent T. Jr
Eggermont, Alexander M. M.
Hellman, Samuel
Kerr, David J.
Article History
First Online: 23 September 2014
Competing interests
: A.M.M.E. is on the scientific advisory board and receives honoraria from Bristol–Myers Squibb and Merck Sharp & Dohme Limited. D.J.K. is Director of the Oxford University spin out company, Oxford Cancer Biomarkers. The other authors declare no competing interests.